Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Telangiectasia”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Testing effectiveness (Phase 2)Study completedNCT00504400
What this trial is testing

Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)

Who this might be right for
Type 2 Idiopathic Macular Telangiectasia
University Hospital, Bonn 10
Testing effectiveness (Phase 2)Study completedNCT04729972
What this trial is testing

Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2

Who this might be right for
Macular Telangiectasia Type 2
Neurotech Pharmaceuticals 33
Testing effectiveness (Phase 2)UnknownNCT01975103
What this trial is testing

Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases

Who this might be right for
Diabetic Macular EdemaBranch Retinal Vein OcclusionChronic Central Serous Retinopathy+1 more
Federal University of Rio Grande do Sul 20
Not applicableLooking for participantsNCT00874783
What this trial is testing

Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases

Who this might be right for
Neurodegenerative Disorders
Hadassah Medical Organization 120
Early research (Phase 1)Study completedNCT01327911
What this trial is testing

Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)

Who this might be right for
Idiopathic Juxtafoveal Telangiectasia
Neurotech Pharmaceuticals 7
Early research (Phase 1)Study completedNCT00685854
What this trial is testing

Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth

Who this might be right for
Macular Telangiectasia
National Eye Institute (NEI) 5
Post-approval studies (Phase 4)Not Yet RecruitingNCT06971939
What this trial is testing

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

Who this might be right for
Macular Telangiectasia Type 2 (MacTel)
Neurotech Pharmaceuticals 285
Early research (Phase 1)Study completedNCT00457145
What this trial is testing

Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation

Who this might be right for
Telangiectasia
National Eye Institute (NEI) 5
Not applicableStudy completedNCT01354093
What this trial is testing

The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)

Who this might be right for
Idiopathic Juxtafoveal Telangiectasia
Paul S. Bernstein 8
Large-scale testing (Phase 3)Study completedNCT03319849
What this trial is testing

Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol B

Who this might be right for
Macular Telangiectasia Type 2
Neurotech Pharmaceuticals 119
Large-scale testing (Phase 3)Not Yet RecruitingNCT07342439
What this trial is testing

Study of Serine Supplementation to Protect Vision in MacTel

Who this might be right for
Macular Telangiectasia Type 2 (MacTel)
The Lowy Medical Research Institute Limited 120
Early research (Phase 1)Study completedNCT00457067
What this trial is testing

Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation

Who this might be right for
Telangiectasia
National Eye Institute (NEI) 5
Testing effectiveness (Phase 2)Study completedNCT03071965
What this trial is testing

Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)

Who this might be right for
MacTel (Macular Telangiectasia) Type 2
Neurotech Pharmaceuticals 70
Large-scale testing (Phase 3)Study completedNCT03316300
What this trial is testing

Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A

Who this might be right for
Macular Telangiectasia Type 2 (MacTel)
Neurotech Pharmaceuticals 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT04907084
What this trial is testing

Serine and Fenofibrate Study in Patients With MacTel Type 2

Who this might be right for
Macular Telangiectasia Type 2
The Lowy Medical Research Institute Limited 60
Large-scale testing (Phase 3)Study completedNCT00451763
What this trial is testing

Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia

Who this might be right for
RetinaTelangiectasis
University of Sao Paulo 31
Large-scale testing (Phase 3)Ended earlyNCT03845049
What this trial is testing

Comparative Multicenter Randomized Study of Aflibercept Versus Placebo in Macular Telangiectasia Type 1

Who this might be right for
Macular Telangiectasia
Centre Hospitalier Universitaire Dijon 16
Early research (Phase 1)Study completedNCT00378196
What this trial is testing

Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial

Who this might be right for
Telangiectasia
Johns Hopkins University 10
Early research (Phase 1)Study completedNCT00685503
What this trial is testing

Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth

Who this might be right for
Neovascularization
National Eye Institute (NEI) 1
Testing effectiveness (Phase 2)Study completedNCT03669393
What this trial is testing

Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1)

Who this might be right for
Retinal TelangiectasisIdiopathic Juxtafoveal Retinal Telangiectasia
ThromboGenics 8
Load More Results